Clinical Trial Update: Pilot Study of Bydureon to Treat Diabetes in HIV-infected Adults [Phase 4]

View source ↗

Summary

This Phase 4 pilot study of Bydureon to treat diabetes in HIV-infected adults was terminated, and results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Human Immunodeficiency Virus Infection

Drugs mentioned

• Bydureon (exenatide)

Snippet

Sponsor: Vanderbilt University | Conditions: Human Immunodeficiency Virus Infection, Diabetes Mellitus | Phase 4 | Status: TERMINATED | Results posted: 2017-03-10